183 related articles for article (PubMed ID: 37817415)
21. Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer.
Fukushima H; Kato T; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Kondo E; Choyke PL; Kobayashi H
Cancer Sci; 2022 Sep; 113(9):3180-3192. PubMed ID: 35723065
[TBL] [Abstract][Full Text] [Related]
22. Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer.
Nakamura Y; Ohler ZW; Householder D; Nagaya T; Sato K; Okuyama S; Ogata F; Daar D; Hoa T; Choyke PL; Kobayashi H
Mol Cancer Ther; 2017 Feb; 16(2):408-414. PubMed ID: 28151706
[TBL] [Abstract][Full Text] [Related]
23. Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.
Kishimoto S; Oshima N; Yamamoto K; Munasinghe J; Ardenkjaer-Larsen JH; Mitchell JB; Choyke PL; Krishna MC
Free Radic Biol Med; 2018 Feb; 116():1-10. PubMed ID: 29289705
[TBL] [Abstract][Full Text] [Related]
24. CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.
Kiss B; van den Berg NS; Ertsey R; McKenna K; Mach KE; Zhang CA; Volkmer JP; Weissman IL; Rosenthal EL; Liao JC
Clin Cancer Res; 2019 Jun; 25(12):3561-3571. PubMed ID: 30890547
[TBL] [Abstract][Full Text] [Related]
25. Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model.
Okada R; Furusawa A; Inagaki F; Wakiyama H; Kato T; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
Cancer Sci; 2021 Aug; 112(8):3041-3049. PubMed ID: 34101947
[TBL] [Abstract][Full Text] [Related]
26. Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination.
Nagaya T; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
Gastric Cancer; 2019 May; 22(3):463-472. PubMed ID: 30171392
[TBL] [Abstract][Full Text] [Related]
27. Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer.
Isobe Y; Sato K; Nishinaga Y; Takahashi K; Taki S; Yasui H; Shimizu M; Endo R; Koike C; Kuramoto N; Yukawa H; Nakamura S; Fukui T; Kawaguchi K; Chen-Yoshikawa TF; Baba Y; Hasegawa Y
EBioMedicine; 2020 Feb; 52():102632. PubMed ID: 31981983
[TBL] [Abstract][Full Text] [Related]
28. Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms.
Ito K; Mitsunaga M; Arihiro S; Saruta M; Matsuoka M; Kobayashi H; Tajiri H
BMC Cancer; 2016 Jan; 16():37. PubMed ID: 26810644
[TBL] [Abstract][Full Text] [Related]
29. Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
Siddiqui MR; Railkar R; Sanford T; Crooks DR; Eckhaus MA; Haines D; Choyke PL; Kobayashi H; Agarwal PK
Sci Rep; 2019 Feb; 9(1):2084. PubMed ID: 30765854
[TBL] [Abstract][Full Text] [Related]
30. Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers.
Cui Y; Xu Y; Li Y; Sun Y; Hu J; Jia J; Li X
Technol Cancer Res Treat; 2023; 22():15330338221145992. PubMed ID: 36734039
[TBL] [Abstract][Full Text] [Related]
31. Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.
Nakajima T; Sano K; Mitsunaga M; Choyke PL; Kobayashi H
Cancer Res; 2012 Sep; 72(18):4622-8. PubMed ID: 22800710
[TBL] [Abstract][Full Text] [Related]
32. Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody.
Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
Mol Cancer Res; 2017 Sep; 15(9):1153-1162. PubMed ID: 28588059
[TBL] [Abstract][Full Text] [Related]
33. MRP1-targeted near infrared photoimmunotherapy for drug resistant small cell lung cancer.
Li F; Mao C; Yeh S; Sun Y; Xin J; Shi Q; Ming X
Int J Pharm; 2021 Jul; 604():120760. PubMed ID: 34077781
[TBL] [Abstract][Full Text] [Related]
34. Combinatory therapy of MRP1-targeted photoimmunotherapy and liposomal doxorubicin promotes the antitumor effect for chemoresistant small cell lung cancer.
Li F; Mao C; Yeh S; Xin J; Wang P; Shi Q; Ming X
Int J Pharm; 2022 Sep; 625():122076. PubMed ID: 35931394
[TBL] [Abstract][Full Text] [Related]
35. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging.
Ito K; Mitsunaga M; Nishimura T; Kobayashi H; Tajiri H
Oncotarget; 2016 Mar; 7(12):14143-52. PubMed ID: 26909859
[TBL] [Abstract][Full Text] [Related]
36. [Near Infrared Photoimmunotherapy for Cancer].
Kobayashi H
Gan To Kagaku Ryoho; 2019 Jan; 46(1):28-33. PubMed ID: 30765637
[TBL] [Abstract][Full Text] [Related]
37. Near infrared photoimmunotherapy with an anti-mesothelin antibody.
Nagaya T; Nakamura Y; Sato K; Zhang YF; Ni M; Choyke PL; Ho M; Kobayashi H
Oncotarget; 2016 Apr; 7(17):23361-9. PubMed ID: 26981775
[TBL] [Abstract][Full Text] [Related]
38. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
[TBL] [Abstract][Full Text] [Related]
39. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody.
Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H
Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622
[TBL] [Abstract][Full Text] [Related]
40. Comparison of low-molecular-weight ligand and whole antibody in prostate-specific membrane antigen targeted near-infrared photoimmunotherapy.
Nakajima K; Miyazaki F; Terada K; Takakura H; Suzuki M; Ogawa M
Int J Pharm; 2021 Nov; 609():121135. PubMed ID: 34571072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]